Published in BMJ on February 27, 2012
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol (2015) 5.43
Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ (2014) 3.48
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry (2017) 1.39
PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Med (2013) 1.36
Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. CMAJ (2013) 1.19
Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons. BMC Med Res Methodol (2012) 1.06
Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies. Int J Epidemiol (2014) 1.05
The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration. Syst Rev (2013) 1.00
Evidence of Experimental Bias in the Life Sciences: Why We Need Blind Data Recording. PLoS Biol (2015) 0.91
Impact of including Korean randomized controlled trials in Cochrane reviews of acupuncture. PLoS One (2012) 0.89
Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials. Trials (2014) 0.87
A new approach to psychiatric drug approval in Europe. PLoS Med (2013) 0.86
Reverse shoulder arthroplasty in acute fractures of the proximal humerus: A systematic review. Int J Shoulder Surg (2013) 0.85
Electronic discharge summary driving advice: Current practice and future directions. Australas Med J (2013) 0.85
Add-on effect of chinese herbal medicine on mortality in myocardial infarction: systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med (2013) 0.83
Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review. BMC Infect Dis (2015) 0.80
Nurse-Led Medicines' Monitoring for Patients with Dementia in Care Homes: A Pragmatic Cohort Stepped Wedge Cluster Randomised Trial. PLoS One (2015) 0.79
Funding source and the quality of reports of chronic wounds trials: 2004 to 2011. Trials (2014) 0.79
Misclassification of acute respiratory distress syndrome after traumatic injury: The cost of less rigorous approaches. J Trauma Acute Care Surg (2015) 0.77
Chinese Herbal Medicine and Salmeterol and Fluticasone Propionate for Chronic Obstructive Pulmonary Disease: Systematic Review and Network Meta-Analysis. Medicine (Baltimore) (2016) 0.77
Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies. PLoS One (2016) 0.77
Effect of integrated infectious disease training and on-site support on the management of childhood illnesses in Uganda: a cluster randomized trial. BMC Pediatr (2015) 0.76
Medication monitoring in a nurse-led respiratory outpatient clinic: pragmatic randomised trial of the West Wales Adverse Drug Reaction Profile. PLoS One (2014) 0.76
Mortality is the only relevant outcome in ARDS: yes. Intensive Care Med (2014) 0.75
Chiropractic Care of an 8-Year-Old Girl With Nonorganic, Primary Nocturnal Enuresis: A Case Report. J Chiropr Med (2016) 0.75
The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials. Trials (2017) 0.75
Why clinical trial outcomes fail to translate into benefits for patients. Trials (2017) 0.75
Meta-epidemiology. Epidemiol Health (2014) 0.75
mHealth and Application Technology Supporting Clinical Trials: Today's Limitations and Future Perspective of smartRCTs. Front Oncol (2017) 0.75
The matching quality of experimental and control interventions in blinded pharmacological randomised clinical trials: a methodological systematic review. BMC Med Res Methodol (2016) 0.75
Blinded Outcome Assessment Was Infrequently Used and Poorly Reported in Open Trials. PLoS One (2015) 0.75
Feedback versus no feedback in improving patient outcome in group psychotherapy for eating disorders (F-EAT): protocol for a randomized clinical trial. Trials (2014) 0.75
Bias in cervical total disc replacement trials. Curr Rev Musculoskelet Med (2017) 0.75
Improved WOMAC score following 16-week treatment with bromelain for knee osteoarthritis. Clin Rheumatol (2016) 0.75
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J (2003) 6.88
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med (2014) 5.98
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ (2010) 5.68
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA (2010) 4.56
Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. J Clin Epidemiol (2010) 4.50
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ (2006) 4.42
Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med (2009) 4.19
Public availability of results of trials assessing cancer drugs in the United States. J Clin Oncol (2013) 3.73
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med (2008) 3.63
Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort study. PLoS Med (2012) 3.33
Taking healthcare interventions from trial to practice. BMJ (2010) 3.27
Challenges in evaluating surgical innovation. Lancet (2009) 2.86
Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J (2005) 2.83
Quality of reporting of noninferiority and equivalence randomized trials. JAMA (2006) 2.79
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis Rheum (2010) 2.68
A critical appraisal of the evidence for using cardiotocography plus ECG ST interval analysis for fetal surveillance in labor. Part I: the randomized controlled trials. Acta Obstet Gynecol Scand (2014) 2.67
Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med (2011) 2.62
Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med (2010) 2.52
What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J (2007) 2.52
Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures. Ann Surg (2014) 2.48
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum (2004) 2.44
Data extraction errors in meta-analyses that use standardized mean differences. JAMA (2007) 2.41
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment. Arthritis Rheum (2008) 2.41
High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe. J Clin Oncol (2005) 2.35
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis (2009) 2.20
The influence of pregnancy on the development of autoimmunity in chronic lymphocytic leukemia. Leuk Lymphoma (2006) 2.07
Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet (2008) 2.03
Lack of head-to-head trials and fair control arms: randomized controlled trials of biologic treatment for rheumatoid arthritis. Arch Intern Med (2012) 1.95
The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: a systematic review. Ann Surg (2006) 1.91
Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. Int J Nurs Stud (2011) 1.88
Splint for base-of-thumb osteoarthritis: a randomized trial. Ann Intern Med (2009) 1.86
Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLoS Med (2013) 1.78
Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med (2007) 1.77
Reporting of sample size calculation in randomised controlled trials: review. BMJ (2009) 1.76
A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol (2005) 1.74
Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS (2004) 1.73
Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. J Clin Epidemiol (2004) 1.71
Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma? J Clin Oncol (2004) 1.68
Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial. Atherosclerosis (2010) 1.60
The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort. J Rheumatol (2009) 1.59
Descriptions of non-pharmacological interventions in clinical trials. BMJ (2013) 1.59
Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. JAMA (2003) 1.58
Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 1.57
Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial. J Rheumatol (2007) 1.57
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Cochrane Database Syst Rev (2014) 1.56
Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. Eur Heart J (2010) 1.53
Bacteremia in patients receiving TNF-alpha antagonists--a prospective multicenter study. J Infect (2013) 1.52
Beneficial effects of information leaflets before spinal steroid injection. Joint Bone Spine (2002) 1.51
Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease. Cardiology (2008) 1.47
Size-adjusted left ventricular outflow tract diameter reference values: a safeguard for the evaluation of the severity of aortic stenosis. J Am Soc Echocardiogr (2009) 1.46
Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants. BMC Med (2012) 1.46
Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon study. Contemp Clin Trials (2010) 1.46
The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine (2007) 1.44
Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. J Rheumatol (2013) 1.42
Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry. Clin Exp Rheumatol (2012) 1.42
Missing data in randomized controlled trials of rheumatoid arthritis with radiographic outcomes: a simulation study. Arthritis Rheum (2008) 1.40
Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy. Ann Rheum Dis (2012) 1.39
[Measures for the performance of diagnostic tests]. Ugeskr Laeger (2005) 1.38
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis (2011) 1.37
Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. J Rheumatol (2007) 1.33
Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis. Ann Intern Med (2009) 1.31
Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review. PLoS Med (2006) 1.31
Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review. Am J Med Sci (2007) 1.31
Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS (2007) 1.28
Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study. BMJ (2012) 1.28
Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions. BMC Med Res Methodol (2008) 1.24
Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med (2012) 1.23
Influence of blinding sequence of radiographs on the reproducibility and sensitivity to change of joint space width measurement in knee osteoarthritis. Arthritis Care Res (Hoboken) (2010) 1.23
Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review. BMJ (2013) 1.22
Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment. Crit Rev Oncol Hematol (2009) 1.22
Preventing bias in cluster randomised trials. PLoS Med (2009) 1.22
Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ (2013) 1.21
Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation (2009) 1.21
Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed. J Clin Epidemiol (2010) 1.21
Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries. Rheumatology (Oxford) (2011) 1.20
Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues. J Rheumatol (2005) 1.19
A priori postulated and real power in cluster randomized trials: mind the gap. BMC Med Res Methodol (2005) 1.19
Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. CMAJ (2013) 1.19